Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Private equity in the 2000s wikipedia , lookup
Environmental, social and corporate governance wikipedia , lookup
Socially responsible investing wikipedia , lookup
Investment banking wikipedia , lookup
Early history of private equity wikipedia , lookup
History of investment banking in the United States wikipedia , lookup
Fact Sheet: DAN VICKERY Cell: 412-877-7944 Website: www.BioEnsemble.com Email: [email protected] Profile: An accomplished Business Development (BD) executive and Deal-Maker with a wide network of contacts in Pharma, Specialty-Pharma, Biotech and Finance, with a special expertise in organization and effective management, and exposure to many therapy areas, dosage forms and drug types. Focuses on providing (BD) and strategic consulting services to a wide range of pharma and biotech clients, many of whom enjoy successful alliances as a result of his services. Independent financier/fundraiser, identifying and raising money for attractive private and public investment ventures across industries, ranging from performing arts, through to mining, and biotech. Education: MBA, Executive Program, 2002; Richard Ivey School of Business, University of Western Ontario, London Ph.D. (Genetics), 1990; B.Sc. (Biology) 1986; University of British Columbia, Vancouver Experience: Licensing, Business Development, and Commercial Strategy: With a start in BD at Parke-Davis in 1998 as a development opportunity, currently have 10 years BD and commercial strategy experience, including strategic marketing, forecasting, market research and international marketing expertise in roles of increasing seniority/complexity; culminating in 9 deals: Title BD Consultant Director, BD Director Commercial Development Associate Director New BD Company Self Employed Bertek/Mylan Pharmacia Parke-Davis Location PA/NJ PA/NC NJ Canada Timing 2005-Present 2003-2005 2001-2003 1998-2000 Deals 2 3 2 2 Company Management/Corporate: During 15 years of significant positions in the Pharmaceutical industry, management experience includes Big Pharma, Specialty Pharma, small Biotech and international positions. As many as 10 direct reports were managed as head of an international regulatory affairs (RA) department. Board experience includes a seat at CLevel Bio, and as Chairperson of the Canadian Association of Professional RA for 2 years. Fundraising/Financing: Integral member of consortia that have raised over $10 MM from private investors for a number of strategic investment opportunities, and many investors have seen significant returns. Continually in search of unique opportunities worthy of investment, and investors keen to fund these exciting projects. Project Xanadu on Broadway C Level BIO Book of Love Film Raise $4MM $6MM $600 K Timing 2005-7 2006-7 2002-3 Outcome Currently playing on Broadway, rave reviews Currently worth $20MM, 300% return on IPO Sundance entry and Showtime feature, Video Pharmaceutical Development: R&D career culminated in 1998 as head of Rx drug Regulatory Affairs for Parke-Davis in Canada: Title Manager, Associate Director RA Manager, RA and Technical Affairs Company Parke-Davis Kabi-Pharmacia Location Canada Canada Timing 1993-1998 1991-1992 Professional Affiliations: Member, Licensing Executive Society, 2002 – Present; Member, American Association for the Advancement of Science, 1990 – Present; Chairperson, Canadian Association of Professional Regulatory Affairs (CAPRA), 1997 – 1999 NDAs/INDs 15 2